OPA1 and migraine disorder: Through the induction of NTG (10 mg/kg) injection, researchers have observed that the end products of the NLRP3 inflammasome, specifically cytokines, elevate neurotrophic factors that play a crucial role in the pathological processes associated with the progression of migraines.